doxepin cream (Rx)

Brand and Other Names:Prudoxin, Xepin, more...Zonalon
  • Print

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

cream

  • 5%

Pruritus

Apply to affected area q6hr

Administration

Allow at least 3-4 hour intervals

No more than 8 days chronic use

Not recommended

Next:

Interactions

Interaction Checker

and doxepin cream

No Results

     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            All Interactions Sort By:
             activity indicator 
            Previous
            Next:

            Adverse Effects

            >10%

            Burning/stinging (23%)

            Drowsiness (20%; esp if applied to >10% BSA)

            1-10%

            Dizziness (2%)

            Dry mouth (10%)

            Eczema exacerbated

            Edema (1%)

            Emotional changes (2%)

            Previous
            Next:

            Warnings

            Contraindications

            Hypersensitivity

            Narrow-angle glaucoma

            Urinary retention

            Side effects increased by MAO inhibitors; discontinue MAOIs 2 weeks before doxepin

            During acute recovery phase of MI

            Cautions

            Risk of drowsiness

            May cause anticholinergic effects (xerostomia, constipation, urinary retention)

            Use caution in patients with decreased intestinal motility, paralytic ileus

            Possibility of significant systemic absorption, resulting in anticholinergic effects

            May cause orthostatic hypotension

            May cause sedation

            Use caution in patients with cardiovascular disease or hepatic or renal impairment

            Allow at least 3-4 hr between applications

            Use caution in patients with thyroid dysfunction or seizure disorder

            Previous
            Next:

            Pregnancy & Lactation

            Pregnancy Category: B

            Lactation: May pass into breast milk; do not nurse

            Pregnancy Categories

            A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

            B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

            C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

            D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

            X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

            NA: Information not available.

            Previous
            Next:

            Pharmacology

            Mechanism of Action

            Potent histamine H1- & H2-receptor antagonist activity

            Pharmacokinetics

            Absorption: Absorptioin possible

            Previous
            Next:

            Images

            Previous
            Next:

            Formulary

            FormularyPatient Discounts

            Adding plans allows you to compare formulary status to other drugs in the same class.

            To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.

            Adding plans allows you to:

            • View the formulary and any restrictions for each plan.
            • Manage and view all your plans together – even plans in different states.
            • Compare formulary status to other drugs in the same class.
            • Access your plan list on any device – mobile or desktop.

            The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.

            Tier Description
            1 This drug is available at the lowest co-pay. Most commonly, these are generic drugs.
            2 This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.
            3 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.
            4 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
            5 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
            6 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
            NC NOT COVERED – Drugs that are not covered by the plan.
            Code Definition
            PA Prior Authorization
            Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
            QL Quantity Limits
            Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
            ST Step Therapy
            Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
            OR Other Restrictions
            Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
            Additional Offers
            Email to Patient

            From:

            To:

            The recipient will receive more details and instructions to access this offer.

            By clicking send, you acknowledge that you have permission to email the recipient with this information.

            Email Forms to Patient

            From:

            To:

            The recipient will receive more details and instructions to access this offer.

            By clicking send, you acknowledge that you have permission to email the recipient with this information.

            Previous
            Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.